These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29055945)

  • 1. Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review.
    Sanguedolce F; Landriscina M; Ambrosi A; Tartaglia N; Cianci P; Di Millo M; Carrieri G; Bufo P; Cormio L
    Urol Int; 2018; 101(2):125-131. PubMed ID: 29055945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing noninvasive recurrences after definitive treatment for muscle-invasive bladder cancer or high-grade upper tract urothelial carcinoma.
    DiBianco JM; George AK; Su D; Agarwal PK
    Curr Opin Urol; 2015 Sep; 25(5):468-75. PubMed ID: 26125507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer.
    Kulkarni GS; Hakenberg OW; Gschwend JE; Thalmann G; Kassouf W; Kamat A; Zlotta A
    Eur Urol; 2010 Jan; 57(1):60-70. PubMed ID: 19740595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations.
    Klaassen Z; Kamat AM; Kassouf W; Gontero P; Villavicencio H; Bellmunt J; van Rhijn BWG; Hartmann A; Catto JWF; Kulkarni GS
    Eur Urol; 2018 Nov; 74(5):597-608. PubMed ID: 30017405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic breast carcinoma to the urinary bladder-a report of 11 cases including a tumor to tumor metastasis.
    Wang G; Zhou C; Conklin C; Hayes MM; Villamil CF; Ostry A; Jones EC
    Virchows Arch; 2019 Mar; 474(3):333-339. PubMed ID: 30607556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review.
    Sanguedolce F; Loizzi D; Sollitto F; Di Bisceglie M; Lucarelli G; Carrieri G; Bufo P; Cormio L
    Oncology; 2017; 92(3):125-134. PubMed ID: 28056456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder.
    Kaushik D; Frank I; Boorjian SA; Cheville JC; Eisenberg MS; Thapa P; Tarrell RF; Thompson RH
    Int J Urol; 2015 Jun; 22(6):549-54. PubMed ID: 25761779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.
    Stenzl A; Cowan NC; De Santis M; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA;
    Eur Urol; 2011 Jun; 59(6):1009-18. PubMed ID: 21454009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy.
    Hajiran A; Azizi M; Aydin AM; Zemp L; Peyton CC; Dhillon J; Nealon S; Reich RR; Cao B; Li R; Manley BJ; Sexton WJ; Gilbert SM
    J Urol; 2021 Jan; 205(1):100-108. PubMed ID: 32783489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder Cancer.
    Novotny V; Froehner M; Ollig J; Koch R; Zastrow S; Wirth MP
    Urol Int; 2016; 96(2):136-41. PubMed ID: 26789626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer.
    Zegarac M; Nikolic S; Gavrilovic D; Jevric M; Kolarevic D; Nikolic-Tomasevic Z; Kocic M; Djurisic I; Inic Z; Ilic V; Santrac N
    J BUON; 2013; 18(4):859-65. PubMed ID: 24344009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary bladder metastases from breast carcinoma: review of the literature starting from a clinical case.
    Gatti G; Zurrida S; Gilardi D; Bassani G; dos Santos GR; Luini A
    Tumori; 2005; 91(3):283-6. PubMed ID: 16206659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metastatic urinary bladder involvement in breast cancer].
    Avargues A; Luján S; Palomar L; Rogel R; Broseta E; Boronat F
    Arch Esp Urol; 2015 Oct; 68(8):676-8. PubMed ID: 26437333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder.
    Ghoneim IA; Miocinovic R; Stephenson AJ; Garcia JA; Gong MC; Campbell SC; Hansel DE; Fergany AF
    Urology; 2011 Apr; 77(4):867-70. PubMed ID: 21296399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognosis of Patients with Liver Metastases from Colorectal Cancer still Depends on Anatomical Presentation more than on Treatments.
    Gobbi PG; Rossi S; Comelli M; Ravetta V; Rosa LL; Brugnatelli S; Corbella F; Delfanti S; Abumalouh I; Dionigi P
    Curr Cancer Drug Targets; 2015; 15(6):511-8. PubMed ID: 26282549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial.
    Zaghloul MS; Christodouleas JP; Smith A; Abdallah A; William H; Khaled HM; Hwang WT; Baumann BC
    JAMA Surg; 2018 Jan; 153(1):e174591. PubMed ID: 29188298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder.
    Rouanne M; Bajorin DF; Hannan R; Galsky MD; Williams SB; Necchi A; Sharma P; Powles T
    Eur Urol Oncol; 2020 Dec; 3(6):728-738. PubMed ID: 33177001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder Cancer.
    Park JC; Gandhi NM; Carducci MA; Eisenberger MA; Baras AS; Netto GJ; Liu JJ; Drake CG; Schoenberg MP; Bivalacqua TJ; Hahn NM
    J Urol; 2016 Apr; 195(4 Pt 1):880-5. PubMed ID: 26598426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer.
    Chakiryan NH; Jiang DD; Gillis KA; Green E; Hajiran A; Hugar L; Zemp L; Zhang J; Jain R; Chahoud J; Poch M; Manley BJ; Li R; Sexton W; Gilbert SM
    J Urol; 2021 Oct; 206(4):924-932. PubMed ID: 34032503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.